Camillo Ricordi, MD, is a leading expert in pancreatic islet transplantation. He has worked with researchers worldwide in developing innovative strategies to transplant pancreatic islets without having to resort to immunosuppressive drugs. Dr. Ricordi invented the world’s first device capable of detecting pancreatic islets, enabling the transplantation of pancreatic cells alone, instead of the entire organ. The “Ricordi Method” is employed today in major medical centers and labs dealing with the treatment of diabetes and islet transplantation. Since 1996, Dr. Ricordi has been scientific director of the Diabetes Research Institute of Miami, the most important center for the treatment of diabetes. He also is a professor of Transplantation Surgery at the University of Miami, and president of the Stacy Joy Goodman Memorial Foundation, one of the most prominent foundations for juvenile diabetes. He is a member of several scientific societies and the founder of the Cell Transplant Society. Dr. Ricordi is a health care expertfor the European Union, the National Institutes of Health, the Canadian Diabetes Association, and the Juvenile Diabetes Foundation. He is a member of the Telethon Scientific Committee.
Dr. Ricordi has been president of the ISMETT board of directors since January 2004.